---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-25-005815"
form_type: "8-K"
ticker: "ABUS"
cik: "0001447028"
company_name: "Arbutus Biopharma Corp"
filed_at: "2025-09-10T23:59:59+00:00"
generated_at: "2026-05-17T06:58:51.126632+00:00"
event_type: "litigation"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Arbutus wins claim construction ruling in patent suit vs Pfizer/BioNTech over COVID-19 vaccine LNP technology

## Summary
- Court adopted Arbutus's proposed construction for 'fully encapsulated' as 'contained inside' in five LNP patents.
- Court rejected Pfizer/BioNTech's proposal and declined to add 'as distinct from partially' used in prior Moderna ruling.
- Patent claims cover lipid nanoparticle compositions used in COMIRNATY COVID-19 vaccine; damages sought.
- Ruling narrows scope of disputed terms, strengthening Arbutus's infringement case; trial on merits pending.
- Arbutus and licensee Genevant Sciences assert five patents against Pfizer/BioNTech in New Jersey action.

## SEC filing metadata
- accession: 0001171843-25-005815
- form_type: 8-K
- ticker: ABUS
- cik: 0001447028
- company_name: Arbutus Biopharma Corp
- filed_at: 2025-09-10T23:59:59+00:00
- event_type: litigation
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1447028/000117184325005815/0001171843-25-005815-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1447028/000117184325005815/f8k_091025.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-25-005815
- JSON: https://secwatch.observer/filing/0001171843-25-005815.json
- Plain text: https://secwatch.observer/filing/0001171843-25-005815.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.